Manual práctico de Trombosis y Hemostasia de la SETH

— 2 8 3 — 1 1 . A n e s t e s i o l o g í a 20. Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, et al.The perioperative management of antithrom- botic therapy: American College of Chest Physicians Eviden- ce-Based Clinical Practice Guidelines (8 th Edition). Chest 2008;133(Suppl 6):299S-339S. 21. Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W, et al. Updated European Heart Rhythm Associa- tion Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 2015;17:1467-507. 22. Schulman S, Carrier M, Lee AY, Shivakumar S, Blostein M, Spen- cer FA, et al.; Periop Dabigatran Study Group. Perioperative Management of Dabigatran: A Prospective Cohort Study. Cir- culation 2015;132(3):167-73. 23. Majeed A, Ågren A, Holmström M, Bruzelius M, Chaireti R, Odeberg J, et al. Management of rivaroxaban- or apixaban-as- sociated major bleeding with prothrombin complex concen- trates: a cohort study. Blood 2017;130(15):1706-12. 24. Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, et al.; BRIDGE Investigators. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med 2015;373(9):823-33. 25. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Ec- kman MH, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombo- sis, 9 th ed: American College of Chest Physicians Evidence-Ba- sed Clinical Practice Guidelines. Chest 2012;141(Suppl 2): e326S-e350S.